“…In contrast to the growing evidence of early and marked structural alterations of the hippocampal region in AD (Nestor et al, 2004), findings regarding the metabolic status of this key area at the early stage of the disease have been somewhat divergent. Hippocampal hypometabolism has been reported in aMCI and mild AD in several PET studies using various methods (De Leon et al, 1997;Ouchi et al, 1998;De Santi et al, 2001;Nestor et al, 2003;Anchisi et al, 2005;Mosconi et al, 2005; but not in others using either similar or different methodological approaches (Minoshima et al, 1994;Desgranges et al, 1998;Ibanez et al, 1998;Ishii et al, 1998;De Leon et al, 2001;Alexander et al, 2002;Herholz et al, 2002;Nestor et al, 2003;Mosconi et al, 2005;Kawachi et al, 2006), even though the finding of significant correlation between relative hippocampal metabolism and severity of episodic memory impairment suggested sensitivity was not the issue. The question of hippocampal metabolic preservation or alteration in early AD is crucial to support clinical diagnosis, to better understand the pathological mechanisms underlying this neurodegenerative disease and to guide pharmacological research.…”